Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
09/1998
09/01/1998US5799649 Method for imaging abdominal aorta and aortic aneurysms
09/01/1998CA2069501C Monoclonal antibody which distinguishes helper inducer and suppressor inducer cd4+ lymphocytes
09/01/1998CA1340023C Tetrapyrrole aminocarboxylic acids
08/1998
08/27/1998WO1998037057A1 Preparation of acid amides and metallisation of compounds
08/27/1998WO1998036784A1 Coated implantable medical device
08/27/1998WO1998016257A3 Stabilized microparticles and their use as ultrasound contrast agents
08/27/1998WO1998011922A3 Method
08/27/1998CA2281948A1 Inhibition of major groove dna binding proteins by modified polyamides
08/27/1998CA2281947A1 Improved polyamides for binding in the minor groove of double stranded dna
08/27/1998CA2281930A1 Design, synthesis and use of specific polyamide dna-binding ligands
08/26/1998EP0860170A1 Isotopic urea tablets
08/26/1998EP0859642A2 Method of detecting cyclooxygenase-2
08/26/1998EP0859604A1 Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
08/26/1998EP0812151A4 Method and apparatus for magnetic resonance imaging of arteries using a magnetic resonance contrast agent
08/26/1998CN1191493A In vivo diabetes test
08/25/1998US5798491 Multi-mechanistic chemical cleavage using certain metal complexes
08/25/1998US5798444 Incorporating derivatives of 2,4,5-triaminopentanoic acid and aminoglutamic acid into peptide during solid phase synthesis
08/25/1998US5798349 Photodynamic therapy: administering, laser irradiation
08/25/1998US5798248 Recombinant mutant thrombin receptor and related pharmaceuticals
08/25/1998US5798092 Metal complexes; contrast agents for medical imaging
08/25/1998US5798091 Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
08/25/1998US5798089 Chelant moieties linked to an aryl moiety by an interrupted alkylene linker
08/25/1998US5797745 Applying an organic iodine solution in conjunction with a sodium hypochlorite solution
08/19/1998EP0701451B1 Emulsions as contrast agents and method of use
08/19/1998EP0660936B1 Up-converting reporters for biological and other assays using laser excitation techniques
08/19/1998EP0652885B1 Tetraazamacrocyclic metal complexes
08/19/1998CN1190899A Improvements in or relating to contrast agents
08/18/1998US5795861 Methods for regulating gastrointestinal motility
08/18/1998US5795860 Analogs for specific oligosaccharide-protein interactions and uses therefor
08/18/1998US5795563 Identification of an exogenous intra-erythrocytic bacterium in patients having systemic lupus erythematosus, and treatment
08/18/1998US5795562 Biodegradable polymer as contrast agents for diagnostic imaging
08/13/1998WO1998034908A1 PROCESS FOR THE CRYSTALLIZATION FROM A LINEAR OR BRANCHED (C5-C6) ALCOHOL OR THEIR MIXTURES OF (S)-N,N'-bis[2-HYDROXY-1- (HYDROXYMETHYL)ETHYL]-5-[ (2-HYDROXY-1-OXOPROPYl)AMINO]-2,4,6- TRIIODO-1,3-BENZENDICARBOXAMIDE
08/13/1998WO1998034905A1 Process for the preparation of iodinated contrast agents and intermediates therefor
08/13/1998WO1998034533A1 Imaging of light scattering tissues with fluorescent contrast agents
08/13/1998WO1998011921A3 Method
08/13/1998CA2280235A1 Process for the preparation of iodinated contrast agents and intermediates therefor
08/12/1998EP0857212A2 Methods and compositions comprising glut-2 and glut-2 chimeras
08/12/1998EP0857071A1 (radio) labelled biotin derivatives
08/12/1998EP0857070A2 Stabilised phospholipid compositions
08/11/1998US5792904 Selecting the plants by evaluating the gene expression and mutant phenotype
08/11/1998US5792901 Detecting prions in a sample and prion preparation and transgenic animal used for same
08/11/1998US5792833 Binds to human papilloma virus
08/11/1998US5792475 Lymphatic delivery composition
08/11/1998US5792445 Polymers and copolymers of acrylic acid MRI of the digestive tract of patients
08/11/1998US5792444 Labeled chemotactic peptides to image focal sites of infection or inflammation
08/11/1998US5792056 Method and apparatus for magnetic resonance imaging of arteries using a magnetic resonance contrast agent
08/06/1998WO1998033530A1 Method for detecting abnormal epithelial cell shedding
08/05/1998EP0856054A1 Monoclonal antibody br110 and uses thereof
08/05/1998EP0855997A1 Formyl derivatives as nonionic contrast media
08/05/1998EP0619716B1 Contrast media
08/05/1998CN1189779A Cascade polymer complexes, its preparation process and medicine containing cascade polymer
08/05/1998CN1189778A Metal complexes of polyaminoacids, and their utilization in diagnostic imaging
08/04/1998US5789921 Magnetic resonance imaging using hyperpolarized noble gases
08/04/1998US5789655 Dna sequences
08/04/1998US5789555 Complexing
08/04/1998US5789554 Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells
08/04/1998US5789420 Azavesamicols
08/04/1998US5789376 Transfusions with stabilized hemoglobin covalently bound to a nitroxide or polymers thereof
08/04/1998US5789164 Agents and a method of chromosome preparation using protein phosphatase inhibitors induced premature chromosome condensation (PCC) technique
08/04/1998CA1339980C Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same
07/1998
07/30/1998WO1998032469A2 Polymers
07/30/1998WO1998032468A1 Contrast agents containing two types of gas filled microbubbles
07/30/1998WO1998018501A3 Improvements in or relating to diagnostic/therapeutic agents
07/30/1998WO1998018495A3 Improvements in or relating to diagnostic/therapeutic agents
07/30/1998CA2278750A1 Contrast agents containing two types of gas filled microbubbles
07/30/1998CA2278200A1 Polymers
07/29/1998EP0855401A1 Nuclear magnetic resonance contrast compositions
07/29/1998EP0855186A2 Gas containing microparticles and their application in ultrasound-diagnostics
07/29/1998EP0854855A1 Lipophilic contrast agents for use in hepatocyte-selective oil-in-water emulsions
07/29/1998EP0854732A2 Contrasting agents for near infrared diagnosis
07/29/1998EP0854716A1 Androgenic directed compositions
07/29/1998EP0854689A2 Improvements in or relating to ultrasound imaging
07/29/1998EP0625990B1 Glycoprotein complexes and glycoproteins
07/29/1998EP0462206B1 Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
07/29/1998CN1189105A Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagenosis
07/28/1998US5786496 High oxidation state metal oxo complexes of the PHAB ligand
07/28/1998US5786322 Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1
07/28/1998US5786157 DNA encoding human 5-HT1D receptors and uses thereof
07/28/1998US5786155 Methods for identifying a compound that binds to a human 5-HT 1E receptor
07/28/1998US5785969 Attaching hydrophobic chains to antibodies in the presence of surface active agents, removing surface active agents, allowing antibodies with attached chains to form micelle-like antibody aggregates
07/28/1998US5785953 Magnetic resonance imaging using hyperpolarized noble gases
07/28/1998US5785950 Perfluorobis(chlorobutyl ether; medical imaging
07/23/1998WO1998031399A2 LABELLED FACTOR XIIIa SUBSTRATES
07/23/1998WO1998018500A3 Improvements in or relating to diagnostic/therapeutic agents
07/22/1998EP0853483A1 Novel peptides
07/22/1998EP0690991B1 Novel anticoagulant cofactor activity
07/22/1998EP0620743B1 Contrast agents consisting of galactose particles and an amphiphilic carboxylic acid
07/21/1998US5783674 Method for the use and synthesis of peptides
07/21/1998US5783306 Hyperpolarizable compounds and devices fabricated therefrom
07/21/1998US5783170 Peptide-metal chelate conjugates
07/21/1998US5783169 Rigid bifunctional chelating agents
07/21/1998CA2067133C Liposome microreservoir composition and method
07/16/1998WO1998030247A1 A method and composition for cancer treatment by enzymatic conversion of soluble radioactive toxic agents
07/16/1998WO1998023297A3 Particulate compositions
07/16/1998WO1998018498A3 Improvements in or relating to diagnostic/therapeutic agents
07/16/1998WO1998018497A3 Contrast agents
07/16/1998WO1998018496A3 Contrast agents
07/15/1998EP0852477A1 A method of magnetic resonance focused surgical and therapeutic ultrasound
07/14/1998US5780670 A ligand comprising five carbonyl ester bond and one ester bond for amidation to bind biological active site
07/14/1998US5780644 Branced polyoxaalkyl macromolecules
1 ... 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 ... 354